Justin Lindhorst, MBA

Many patients face significant challenges in accessing their specialty medications, which highlights the importance of pharmacy-deployed patient navigation programs designed to help resolve nonclinical, system-related barriers to care.

Oncology pharmacists must think critically about the digital experience they give patients.

Specialty pharmacies are well positioned to address disparities that affect outcomes.

Health systems should review HHS’ action plan and determine how to leverage cost savings to help eradicate HCV.

Effective specialty pharmacies learn to meet the changing needs of patients and stakeholders.

Drug manufacturers participating in Medicaid offer lower prices, stretching resources and providing comprehensive services to more patients.

Many HTCs use these drug pricing arrangements to reduce reliance on limited federal funding.

Specialty pharmacies are uniquely positioned to thrive in the era of value-based health care.

Study results have demonstrated that pharmacists are effective partners in improving care, reducing cost, and avoiding drug complications for patients with cancer.

The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.